Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
British Journal of Clinical Pharmacology|October 6, 1999
Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descentH G Xie, R B Kim, C M Stein, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1986
Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerationsC B McAllister, H T Wolfenden, W S Aslanian, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Effect of aging and cigarette smoking on antipyrine and indocyanine green eliminationA J Wood, R E Vestal, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|June 1, 1982
Furosemide disposition in cirrhosisR K Verbeeck, R V Patwardhan, J P Villeneuve, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 24, 1997
Activity and tolerance of a continuous subcutaneous infusion of interferon-alpha2b in patients with chronic hepatitis CS Schenker, D Cutler, J Finch, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein bindingD R Jones, S D Hall, E K Jackson, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphismP J Wedlund, W S Aslanian, C B McAllister, et al.
Pageof 26